New Delhi, May 13, 2015: The figures of Hepatitis C affected Indians who could not afford medical treatment are not collected centrally. However, the cost of treatment for Hepatitis C is high for the cases which require treatment. The Government of India has launched a National Programme for prevention and control of viral Hepatitis during 12thFive Year Plan period under which the activities undertaken, inter alia, are:
1. Laboratory network for laboratory based surveillance of viral hepatitis in different geographical locations of India, in a phased manner.
2. Setting up of one Reference Laboratory at National Centre for Disease Control (NCDC), Delhi.
3. Training and capacity building of professionals in relevant sectors, like Microbiologists, Laboratory Technicians, data Managers and Field Workers.
4. Laboratory support for outbreak investigation of hepatitis through established network of laboratories.
5. Development of guidelines and creating awareness for prevention and control and treatment of blood borne and water borne hepatitis.
6. Information Education and communications (IEC) for dissemination of information about prevention and control of viral hepatitis.
Central Drugs Standard Control Organization (CDSCO) has granted import and marketing permission on 13th January, 2015 for Sofosubuvir 400 mg tablet (brand name Sovaldi) manufactured by M/s Gilead Science Ltd., to M/s Mylan Pharma Pvt. Ltd. for treatment of chronic Hepatitis C in adults.
Subsequently, CDSCO has also granted permission to manufacture and market Sofosubuvir 400 mg tablet in March, 2015 to Indian manufacturers namely, M/s Hetero Labs. and Natco Pharma. CDSCO has no information about cost of the drug.
The Minister for Health & Family Welfare, Shri J P Nadda stated this in a written reply in the Rajya Sabha.
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…